UBS Group’s AllianzIM U.S. Equity Buffer10 Nov ETF NVBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.12K Buy
+115
New +$4.23K ﹤0.01% 8987
2025
Q4
Sell
-2,823
Closed -$102K 10973
2025
Q3
$102K Sell
2,823
-1,980
-41% -$69.7K ﹤0.01% 7114
2025
Q2
$165K Buy
4,803
+2,448
+104% +$79.3K ﹤0.01% 6848
2025
Q1
$75.1K Buy
+2,355
New +$77.3K ﹤0.01% 7268
2024
Q4
Sell
-4,817
Closed -$153K 10253
2024
Q3
$153K Sell
4,817
-3,337
-41% -$105K ﹤0.01% 6061
2024
Q2
$254K Buy
8,154
+5,906
+263% +$181K ﹤0.01% 5505
2024
Q1
$68.4K Buy
2,248
+526
+31% +$15.7K ﹤0.01% 6374
2023
Q4
$50.2K Buy
+1,722
New +$48.3K ﹤0.01% 6535

Other funds holding NVBT

UBS Group's NVBT Position: Q1 2026 in Review

UBS Group opened a new position in AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) in Q1 2026: 115 shares worth $4.12K. The stake represents ﹤0.01% of the portfolio and ranks #8987 among its holdings. This is a return to the name: UBS Group previously reported a position in NVBT as recently as Q3 2025.

UBS Group first reported a position in NVBT in Q4 2023 and has held it in 8 quarters since. The position peaked at $254K in Q2 2024. 27 funds tracked by Wall St. Rank hold NVBT as of Q1 2026.

  • UBS Group held 115 shares of AllianzIM U.S. Equity Buffer10 Nov ETF worth $4.12K as of Q1 2026.
  • AllianzIM U.S. Equity Buffer10 Nov ETF was a new UBS Group position in Q1 2026.
  • AllianzIM U.S. Equity Buffer10 Nov ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8987 holding.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer10 Nov ETF in Q4 2023 and has held it in 8 quarters since.
  • UBS Group's AllianzIM U.S. Equity Buffer10 Nov ETF position peaked at $254K in Q2 2024.
  • 27 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Nov ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.